ProFACT NewsProFACT to Present at Online Conference Mining For Cancer Biomarkers12/08/2011 HemoVoid™ utility cited in red blood cell journal article11/18/2011 WEBINAR Sept 20, 2011 SeraFILE PROspector09/09/2011
Sign up for a free webinar, Tuesday September 20, 10-11 AM US Eastern Standard Time
This webinar will discuss how to employ SeraFILE PROspector™ for use in differential proteomics and molecular profile characterization to discrminate parent proteome content at the functional conformation level, to evaluate drug responsiveness, and for drug target and functional biomarker discovery. ......Full Story RECORDED WEBINAR: Proteomics Innovation Network08/10/2011 New Product Release: SeraFILE PROspector for functional proteomics separations and enrichment05/19/2011 Proteomics Innovation Network of Service and Product Providers Formed05/13/2011 New Proteomic Sample Prep Product to Enrich Cyclic Nucleotide Phosphodiesterases05/10/2011 1-On-1 PERSONAL WEBINAR INVITATION02/01/2011
1-On-1 PERSONAL WEBINAR INVITATION on
Applying SeraFILE for Functional Proteomic Profiling and Prospecting
Give Us your available date and time between M-F 8:00am to 11:00 PM EST in the registration form provided and we will accomodate your schedule ......Full Story Personal 1-on-1 Webinar Invitation: Functional Proteomic Profiling of Phosphodiesterases and Kinases02/01/2011
1-On-1 PERSONAL WEBINAR INVITATION on Functional Proteomic Profiling of Phosphodiesterases and Kinases
Give Us your available date and time between M-F 8:00am to 11:00 PM EST in the registration form provided and we will accommodate your schedule. ......Full Story New Proteomic Sample Prep Product For Kinase Enrichment12/22/2010 ACHIVED WEBINAR: Functional Proteomic Profiling of Phosphodiesterases and Kinases12/16/2010
In this webinar, ProFACT describes advances in its proprietary functional proteomics platform – SeraFILE™, and related Conformerics™ prospecting strategies, for the purposes of: 1) proteomic analyses for broadly relating and characterizing the kinetics of enzyme variants responsible for the disease phenotype, and 2) proteomic analyses to assess drug responsiveness based on enzyme kinetics from heterogeneous mixtures such as from cell lines and tissue homogenates. ......Full Story
ProFACT Received Therapeutic Discovery Project (QTDP) Grant11/16/2010
Monmouth Junction, NJ, October 29, 2010: ProFACT Proteomics, Inc. of Monmouth Junction, NJ is the recipient of a Qualifying Therapeutic Discovery Project (QTDP) Grant from the US Department of the Treasury for its project SeraFILE™: Conformational Variants (Conformers) for Drug and Biomarker Discovery. ......Full Story
ARCHIVED WEBINAR
|
